vktx stock forecast zacks
Meanwhile note that the median VKTX forecast price target median being the middle where half of analysts had a higher VKTX forecast and half had a lower VKTX forecast which is a different metric than the average or mean was 135 as of 2022-06-20 while the highest VKTX forecast in the analyst group was 280 and the lowest VKTX forecast. Annual revenue last year 000.
Just 99 for a limited time normally 199 days Hours Minutes Seconds.
. Buy or sell Viking Therapeutics stock. Moreover VKTX currently has a Zacks Rank 2 Buy which means it is in the top 20 of more than the 4000 stocks that we rank based on. Also this average forecast of 110 represents a -1538 decrease from the past average forecast of 130 6 months ago from 1.
Viking Therapeutics stock forecast by Wall Street Analysts. View real-time stock prices and stock quotes for a full financial overview. 298 -350 This stock has very high daily movements and this gives very high risk.
Get the latest Decibel Therapeutics NASDAQDBTX stock forecast price target earnings estimates news headlines short interest at MarketBeat. Viking continues to anticipate enrollment completing in the first half of 2021 which could lead to 12-week liver fat data being available by the end of 2021 or early 2022. Viking Therapeutics broker recommendation chart.
During the last day the stock moved 029 between high and low or 963. Moreover VKTX currently has a Zacks Rank 2 Buy which means it is in the top 20 of more than the 4000 stocks that we rank based on trends in earnings estimate revisions. Find the latest Viking Therapeutics Inc.
According to 16 analysts the average rating for VKTX stock is Buy The 12-month stock price forecast is 1791 which is an increase of 48149 from the latest price. Viking Therapeutics Inc Stock Market info Recommendations. Viking continues to anticipate enrollment completing in the first half of 2021 which could lead to 12-week liver fat data being available by the end of 2021 or early 2022.
There is a buy signal from a pivot bottom found 12 days ago. Stock Forecast Zacks Mars Architects Com Nhvmi0bvtp Nam Share this. Viking is currently conducting a Phase 1 clinical trial of VK0214 in.
Viking Therapeutics Inc 318 008 245 Watch. 32668 Upside Based on 4 Wall Street analysts offering 12 month price targets for Decibel Therapeutics in the last 3 months. Viking Therapeutics Inc.
Rooms Rankings Earnings Newsletters Shop. Wall Street Stock Market Finance report prediction for the future. Youll find the Viking Therapeutics share forecasts stock quote and buy sell signals belowAccording to present data Viking Therapeuticss VKTX shares and potentially its market environment have been in bearish.
In addition the company is continuing to open additional sites both in the US. 50 OFF MarketBeat Daily Premium. Viking is currently conducting a Phase 1 clinical trial of VK0214 in.
The average price target represents a 32668 change from the last price of 461. 2022 at 1006 am. NASDAQVKTX is not the most popular stock in this group but hedge fund interest is still above average.
Get the latest chart with broker recommendations from Zacks Investment Research. 100 the week before that. Find real-time VKTX - Viking Therapeutics Inc stock quotes company profile news and forecasts from CNN Business.
2 Wall Street analysts that have issued a 1 year VKTX price target the average VKTX price target is 1100 with the highest VKTX stock price forecast at 1200 and the lowest VKTX stock price forecast at 1000. Analyst Price Target on DBTX. Skip to main content.
The average Viking Therapeutics stock forecast from last 6 month is 110 and this show a -2903 decrease in average from the prior price target of the each prediction. VKTX analyst stock forecast price target and recommendation trends with in-depth analysis from research reports. SP 500 262 DOW 137.
Real-time trade and investing ideas on Viking Therapeutics Inc VKTX from the largest community of traders and investors. For the last week the stock has had a daily average volatility of 881. In addition the company is continuing to open additional sites both in the US.
The average price target is 1967 with a high forecast of 2300 and a low forecast of 1500. EPS forecast this quarter-021.
2 Strong Buy Penny Stocks That Could Spike Over 200
Eliem Announces Updated Development Plans And The Advancement Of Etx 155 For The Iq Stock Market
Vktx220819p00006000 Vktx220819p00006000 Interactive Stock Chart Yahoo Finance
Zacks Trade Review The Advanced Traders Ideal Interface Stock Options Trading Online Broker Interactive Brokers
Intercept Icpt Q4 Earnings Sales Beat Ocaliva In Focus Nasdaq
Intercept Icpt Outperforms Industry In 3 Months What Lies Ahead Nasdaq
Xtr Uuhugg R5m
Drrx Pipeline Update Focus Is On Accelerating Dur 928 In Nash And Other High Potential Indications Ceo Money From Wfn1
Oxhfh94x2othbm
2 Strong Buy Penny Stocks That Could Spike Over 200
Pfizer Pfe Gets Fast Track Designation For Nash Therapy Nasdaq
Lipocine Imminent Catalysts In Nash And Oral Testosterone Replacement Therapy Make For A Strong Buy Nasdaq Lpcn Seeking Alpha
Tsem Growth Should Return To Towerjazz In Q2 Ceo Money From Wfn1
Lipocine Imminent Catalysts In Nash And Oral Testosterone Replacement Therapy Make For A Strong Buy Nasdaq Lpcn Seeking Alpha
Morgan Stanley Portfolio Holdings Aum 13f 13g
Xtr Uuhugg R5m
Follow Truthtracer S Truthtracer Latest Tweets Twitter
Lipocine Imminent Catalysts In Nash And Oral Testosterone Replacement Therapy Make For A Strong Buy Nasdaq Lpcn Seeking Alpha
Tc Tsqdslhzkbm
